BNTC

NASDAQ open

Benitec Biopharma

7.96 USD
▼-0.18-2.21%
盘后 8.81 0.00%
2026-11-20
市值
$285.88M
市盈率
—
EPS
-1.02
股息率
—
52 周区间
7.89 – 14.39
成交量
63.99K
Beta
0.24
目标价
23.75
52W 低 7.8952W 高 14.39
价格走势

公司简介

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence...